Immune Checkpoint Inhibitors and Radiotherapy in NSCLC Patients: Not Just a Fluke

by Lorenzo Belluomini, Francesco Fiorica, Antonio Frassoldati
Published 2019-01-01

Modern Challenges for Early-Phase Clinical Trial Design and Biomarker Discovery in Metastatic Non-Small-Cell Lung Cancer

by Antonio Rossi, Sara Pilotto, Luisa Carbognin, Miriam Grazia Ferrara, Lorenzo Belluomini, Gennaro Daniele, Emilio Bria
Published 2021-06-01

Infections and Immunotherapy in Lung Cancer: A Bad Relationship?

by Lorenzo Belluomini, Alberto Caldart, Alice Avancini, Alessandra Dodi, Ilaria Trestini, Dzenete Kadrija, Marco Sposito, Daniela Tregnago, Miriam Casali, Silvia Teresa Riva, Giulia Sartori, Jessica Menis, Michele Milella, Sara Pilotto
Published 2021-12-01

How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center

by Giulia Pasello, Giulia Pasello, Jessica Menis, Jessica Menis, Sara Pilotto, Stefano Frega, Lorenzo Belluomini, Federica Pezzuto, Anna Caliò, Matteo Sepulcri, Nunzia Luna Valentina Cernusco, Marco Schiavon, Maurizio Valentino Infante, Marco Damin, Claudio Micheletto, Paola Del Bianco, Riccardo Giovannetti, Laura Bonanno, Umberto Fantoni, Valentina Guarneri, Valentina Guarneri, Fiorella Calabrese, Federico Rea, Michele Milella, PierFranco Conte, PierFranco Conte
Published 2021-06-01